Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation
Molecular Pharmaceutics · 07.08.2023 · 20 (8) · 4196-4209
DOI: 10.1021/acs.molpharmaceut.3c00313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.06.2023. Verfasst von Rahul Lalge und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-177 WDH, 308 Harvard Street S.E., Minneapolis, Minnesota 55455, United S…. Hauptthemen laut MEDLINE: Povidone, Polymers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: William and Mildred Peters endowment fund.
Abstract (Originalsprache)
In an earlier investigation, the critical cooling rate to prevent drug crystallization (CRcrit) during the preparation of nifedipine (NIF) amorphous solid dispersions (ASDs) was determined through a time-temperature transformation (TTT) diagram (Lalge et al. Mol. Pharmaceutics 2023, 20 (3), 1806-1817). The current study aims to use the TTT diagram to determine the critical cooling rate to prevent drug nucleation (CRcrit N) during the preparation of ASDs. ASDs were prepared with each polyvinylpyrrolidone (PVP) and hydroxypropyl methylcellulose acetate succinate (HPMCAS). The dispersions were first stored under conditions promoting nucleation and then heated to the temperature that favors crystallization. The crystallization onset time (tC) was determined by differential scanning calorimetry and synchrotron X-ray diffractometry. TTT diagrams for nucleation were generated, which provided the critical nucleation temperature (50 °C) and the critical cooling rate to avoid nucleation (CRcrit N). The strength of the drug-polymer interactions as well as the polymer concentration affected the CRcrit N, with PVP having a stronger interaction than HPMCAS. The CRcrit of amorphous NIF was ∼17.5 °C/min. The addition of a 20% w/w polymer resulted in CRcrit of ∼0.05 and 0.2 °C/min and CRcrit N of ∼4.1 and 8.1 °C/min for the dispersions prepared with PVP and HPMCAS, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-177 WDH, 308 Harvard Street S.E., Minneapolis, Minnesota 55455, United States.
ORCID-Profile: Rahul Lalge, Raj Suryanarayanan
Förderung
- William and Mildred Peters endowment fund
Zitieren
APA
Lalge, R., Kumar, N. S. K., & Suryanarayanan, R. (2023). Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation. Molecular Pharmaceutics, 20(8), 4196-4209. https://doi.org/10.1021/acs.molpharmaceut.3c00313
Vancouver
Lalge R, Kumar NSK, Suryanarayanan R. Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation. Molecular Pharmaceutics. 2023;20(8):4196-4209. doi:10.1021/acs.molpharmaceut.3c00313
BibTeX
@article{Lalge2023,
author = {Lalge, Rahul and Kumar, N S Krishna and Suryanarayanan, Raj},
title = {Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {8},
pages = {4196--4209},
doi = {10.1021/acs.molpharmaceut.3c00313}
}
EUVIMED